side effects of tirzepatide and semaglutide caused roughly half as many patients to stop treatment because gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Tirzepatide vs Semaglutide: Key Differences,

Men who maintained a basic resistance training schedule (2-3 sessions per week) during the trial preserved significantly more lean mass than sedentary participants

F prausnitzii abundance doubled following the administration of a GLP-1 receptor agonist, leading researchers to believe that this may be one of the ways the medication works to improve glucose tolerance

Your doctor should monitor your TSH and free T4 levels before starting treatment and 68 weeks after your dose stabilizes

AuNPs are toxic in vitro and in vivo: a review

If pregnant or lactating, consult your physician before using this product

Meal Shake Muscle Loss When losing weight on a GLP-1, you are losing not only fat, but also muscle mass